Aminoglycoside antibiotics in neonatal foals

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 25, Issue 6, 2003, Pages 457-469

  McKenzie III, Harold C ^a   Furr, Martin O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); EQUIDAE; NEGIBACTERIA;

EID: 0042158760     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Grondahl G, Johannisson A, Demmers S, et al: Influence of age and plasma treatment on neutrophil phagocytosis and CD 18 expression in foals. Vet Microbiol 65(3):241-254, 1999.
2. Paradis MR: Update on neonatal septicemia. Vet Clin North Am Equine Pract 10(1):109-135, 1994.
3. Edson RS, Terrell CL: The aminoglycosides. Mayo Clin Proc 66(11):1158-1164, 1991.
4. Carryn S, Van Bambeke F, Mingeot-Ledercq MP, et al: Comparative inttacellular (THP-1 macrophage) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrob Agents Chemother 46(7):2095-2103, 2002.
5. Kuhar MJ, Mak LL, Liettman PS: Autoradiographic localization of [3H] gentamicin in the proximal renal tubules of mice. Antimicrob Agents Chemother 15(1):131-133, 1979.
6. Breideis DJ, Robson HG: Cerebrospinal fluid penetration of amikacin. Antimicrob Agents Chemother 13:1042-1043, 1978.
7. Brown MP, Embertson RM, Gronwall RR, et al: Amikacin sulfate in mares: Pharmacokinetics and body fluid and endometrial concentrarions after repeated intramuscular administration. Am J Vet Res 45(8):1610-1613, 1984.
8. Goitein K, Michel J, Sacks T: Penetration of parenteratty admin-istered gentamicin into the cerebrospinal fluid in experimental meningitis. Chemotherapy 21(3-4):181-188, 1975.
9. Brown RB, Kruse JA, Counts GW, et al: Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group. Antimicrob Agents Chemother34(2):269-272, 1990.
10. Godber LM, Walker RD, Stein GE, et al.: Pharmacokinetics, nephrotoxicosis, and in vitro antibacterial activity associated with single versus multiple (three times) daily gentamicin treatments in horses. Am J Vet Res 56(5):613-618, 1995.
11. McKenzie HC, Murray MJ: Concentrations of gentamicin in serum and bronchial lavage fluid after intravenous and aerosol administration of gentamicin to horses. Am J Vet Res 61(10): 1185-1190, 2000.
12. Orsini JA, Benson CE, Spencer PA, et al: Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses. Am J Vet Res 50(6)323-925, 1989.
13. Beech J, Kohn C, Leitch M, et al Therapeutic use of gentamicin in horses: Concentrations in serum, urine, and synovial fluid and evaluation of renal function. Am J Vet Res 38(7):1085-1087, 1977.
14. Nix DE, Goodwin SD, Peloquin CA, et al: Antibiotic tissue penetration and its relevance: Impact of tissue penetration on infection response. Antimicrob Agents Chemother 35(10): 1953-1959, 1991.
15. Fisman DN, Kaye KM: Once-daily dosing of aminoglycoside antibiotics. Infect Dis Clin North Am 14(2):475-487, 2000.
16. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM: Aminoglycosides: Activity and resistance. Antimicrob Agents Chemother 43(4):727-737, 1999.
17. Davis BD: Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 51(3):341-350, 1987.
18. Riviere JE, Spoo JW: Aminoglycoside antibiotics, in HR Adams (ed): Veterinary Pharmacology and Therapeutics. Ames, Iowa State University Press, 2001.
19. Darras-Joly C, Bedos JP, Sauve C, et al: Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumonide in a mouse pneumonia model. Antimicrob Agents Chemother 40(9): 2147-2151, 1996.
20. Schlegel L, Sissia G, Fremaux A, et al: In vitro killing activity of combinations of β-lactam agents with aminoglycosidcs against penicillin-resistant pneumococci. J Antimicrob Chemother 39(1):95-98, 1997.
21. Craig WA: Once-daily versus multiple-daily dosing of aminoglycosides. J Chemother 7(Suppl 2):47-52, 1995.
22. Kashuba AD, Nafziger AN, Drusano GL, et al: Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrob Agents Chemother 43(3): 623-629, 1999.
23. Magdesian KG, Hogan PM, Cohen ND, et al: Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses. JAVMA 213(7):1007-1011, 1998.
24. Orsini JA, Soma LR, Rourke JE, et al: Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration. J Vet Pharmacol Ther 8 (2):194-201, 1985.
25. den Hollander JG, Mouton JW, van Goor MP, et al: Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 40(3):784-786, 1996.
26. Craig WA: Post-antibiotic effects in experimental infection models: Relationship to in vitro phenomena and to treatment of infections in man. J Antimicrob Chemother 31(Suppl D):149-158, 1993.
27. Daikos GL, Jackson GG, Lolans VT, et al: Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J Infect Dis 162(2):414-420, 1990.
28. Daikos GL, Lolans VT, Jackson GG: First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother 35(1): 117-123, 1991.
29. Begg EJ, Barclay ML, Kirkpatrick CM: The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol 52(Suppl 1): 35S-43S, 2001.
30. Mingeot-Leclercq MP, Tulkens PM: Aminoglycosides: Nephrotoxicity. Antimicrob Agents Chemother 43(5):1003-1012, 1999.
31. Rybak MJ, Abate BJ, Kang SL, et al: Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 43(7):1549-1555, 1999.
32. Jose-Cunilleras E, Hinchcliff KW: Renal pharmacology. Vet Clin North Am Equine Pract 15(3):647-664, ix, 1999.
33. Brashier MK, Geor RJ, Ames TR, et al: Effect of intravenous calcium administration on gentamicin-induced nephrotoxicosis in ponies. Am J Vet Res 59(8):1055-1062, 1998.
34. Lepper PM, Held TK, Schneider EM, et al: Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med 28(7):824-833, 2002.
35. Trautmann M, Zick R, Rukavina T, et al: Antibiotic-induced release of endotoxin: In vitro comparison of meropenem and other antibiotics. J Antimicrob Chemother 41(2):163-169, 1998.
36. Bentley AP, Barton MH, Lee MD, et al: Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals. Am J Vet Res 63(5):660-668, 2002.
37. Ishikawa M, Miyauchi T, Yagi K, et al: Clinical relevance of antibiotic-induced endotoxin release in patients undergoing hepatic resection. World J Surg23(1):75-79, 1999.
38. Riviere JE: Comparative pharmacokinetics: Principles, techniques, and applications, ed 1. Ames, Iowa State University Press, 1999.
39. Tod MM, Padoin C, Petitjean O: Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: Simple or complex pharmacokinetic methods? Clin Pharmacokinet 40(11):803-814, 2001.
40. Wichtel ME, Buys E, DeLuca J, et al: Pharmacologic considerations in the treatment of neonatal septicemia and its complications. Vet Clin North, Am Equine Pract 15(3):725-746, 1999.
41. Golenz MR, Wilson WD, Carlson GP, et al: Effect of route of administration and age on the pharmacokinetics of amikacin administered by the intravenous and intraosseous routes to 3- and 5-day-old foals. Equine Vet J 26(5):367-373, 1994.
42. Green SL, Conlon PD, Mama K, et al: Effects of hypoxia and azotaemia on the pharmacokinetics of amikacin in neonatal foals. Equine Vet J 24(6):475-479, 1992.
43. Green SL, Conlon PD: Clinical pharmacokinetics of amikacin in hypoxic premature foals. Equine Vet J 25(4):276-280, 1993.
44. Raisis AL, Hodgson JL, Hodgson DR: Serum gentamicin concentrations in compromised neonatal foals. Equine Vet J 30(4):324-328, 1998.
45. Cummings LE, Guthrie AJ, Harkins JD, et al: Pharmacokinetics of gentamicin in newborn to 30-day-old foals. Am J Vet Res 51(12):1988-1992, 1990.
46. Wichtel MG, Breuhaus BA, Aucoin D: Relation between pharmacokinetics of amikacin sulfate and sepsis score in clinically normal and hospitalized neonatal foals. JAVMA 200(9): 1339-1343, 1992.
47. Pedersoli WM, Belmonte A, Purohit RC, et al: Pharmacokinetics of gentamicin in the horse. Am J Vet Res 41(3)351-354, 1980.
48. Magdesian KG, Hogan PM, Cohen ND, et al: Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses. JAVMA 213(7):1007-1011, 1998.
49. Tang GJ, Tang JJ, Lin BS, et al: Factors affecting gentamicin pharmacokinetics in septic patients. Acta Anaesthesiol Scand 43(7):726-730, 1999.
50. Marik PE: Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anaesth Intensive Care 21 (2): 172-173, 1993.
51. Jones SL, Wilson WD, Milhalyi JE: Pharmacokinetics of gentamicin in healthy adult horses during intravenous fluid afiministration. J Vet Pharmacol Ther 21(3):247-249 1998.
52. Pennington JE, Dale DC, Reynolds HY, et al: Gentamicin sulfate pharmacokinetics: Lower levels of gcntamicin in blood during fever. J Infect Dis 132(3):270-275, 1975.
53. McKenzie HC, Fun MO: Equine Neonatal Sepsis: The pathophysiology of severe inflammation and infection. Compend Contin Educ Pract Vet 23(7):661-672, 2001.
54. Hansen M, Christrup LL, Jarlov JO, et al: Gentamicin dosing in critically ill patients. Acta Anaesthesiol Scand 45(6):734-740, 2001.
55. nd AAEP Annu Conv:209-222, 1986.
56. Koterba AM: Antibiotic therapy, in PC Kosch (ed): Equine Clinical Neonatology. Philadelphia, Lea & Febiger, 1990.
57. Hatala R, Dinh T, Cook DJ: Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann Intern Med 124(8):717-725, 1996.
58. Tudor RA, Papich MG, Redding WR: Drug disposition and dosage determination of once daily administration of gentamicin sulfate in horses after abdominal surgery. JAVMA 215(4): 503-506, 1999.
59. rd AAEP Annu Conv:398-400, 1997.
60. rd AAEP Annu Conv:396-397, 1997.
61. van Lent-Evers NA, Mathor RA, Geus WP, et al: Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosidcs on clinical outcome: A cost-effectiveness analysis. Ther Drug Monit 21(1):63-73, 1999.
62. Kashuba AD, Bertino JS, Nafziger AN: Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms. Antimicrob Agents Chemother 42(7):1842-1844, 1998.
63. Edwards DJ, Love DN, Raus J, et al: The nephrotoxic potential of neomycin in the horse. Equine Vet J 21(3):206-210, 1989.
64. Rossier Y, Divers TJ, Sweeney RW: Variations in urinary gamma glutamyl transferase/urinary creatinine ratio in horses with or without pleuropneumonia treated with gentamicin. Equine Vet J 27(3):217-220, 1995.
65. Osborn JL, Hoversten LG, DiBona GF: Impaired blood flow autoregulation in nonfiltering kidneys: Effects of theophylline administration. Proc Soc Exp Biol Med 174(3):328-335, 1983.
66. Adams R, McClure JJ, Gossett KA, et al: Evaluation of a technique for measurement of gamma-glutamyltranspeptidase in equine urine. Am J Vet Res 46(1):147-150, 1985.
67. Schentag JJ, Cumbo TJ, Jusko WJ, et al: Gentamicin tissue accumulation and nephrotoxic reactions. J Am Med Assoc 240(19): 2067-2069, 1978.
68. Humes HD: Aminoglycoside nephrotoxicity. Kidney Int 33(4): 900-911, 1988.
69. Dahlgren JG, Andersen ET, Hewitt WL: Gentamicin blood levels: A guide to nephroroxicity. Antimicrob Agents Chemother 8(1):58-62, 1975.
70. Sojka JE, Brown SA; Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis. JAVMA 189(7):784-789, 1986.
71. Morris RG, Sallustio BC, Vinks AA, et al: Some international approaches to aminoglycoside monitoring in the extended dosing interval era. Ther Drug Monit 21(4):379-388, 1999.
72. Begg EJ, Barclay ML, Duffull SB: A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 39(6):605-609, 1995.
73. Kellum JA, JM Decker Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 29(8):1526-1531, 2001.
74. Gronwall R, Brown MP, Hobbs S: Serum gentamicin concentrations and pharmacokinetics in 2-week-old pony foals after intramuscular administration. J Equine Vet Sci 8(3):205-207, 1988.
75. Buijk SE, Mouton JW, Gyssens IC, et al: Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med 28(7):936-942, 2002.